𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation

✍ Scribed by Shinichiro Ochi; Koichiro Kawasoe; Masao Abe; Ryuji Fukuhara; Kantaro Sonobe; Kentaro Kawabe; Shu-ichi Ueno

Book ID
113635925
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
144 KB
Volume
33
Category
Article
ISSN
0163-8343

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroleptic malignant syndrome associate
Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent
✍ Heidi Lee; James Ryan; George Mullett; Brian A. Lawlor πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 248 KB

Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidon